Market Research Assistance
- + 1-888-391-5441
- [email protected]
On the Web 
Central Nervous System (CNS) therapeutics Market Research Reports
Central Nervous System (CNS) therapeutics Market Research Reports
| Title | published | price | |
|---|---|---|---|
Rett Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... tt Syndrome (Central Nervous System) pipeline landscape.
Rett syndrome is a neurodevelopmental disorder. This is caused by genetic mutation on MECP2 gene. Rett syndrome is described in four stages: Stage I or early onset, Stage II or rap......" | 29-Jul-2022 | $2000 | |
Guillain-Barre Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... n overview of the Guillain-Barre Syndrome (Central Nervous System) pipeline landscape.
Guillain-Barre syndrome (GBS) is a disorder in which the body's immune system attacks part of the peripheral nervous system. The first symptoms of thi......" | 29-Jul-2022 | $2000 | |
Narcolepsy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... sy (Central Nervous System) pipeline landscape.
Narcolepsy is a sleep disorder that causes excessive sleepiness and frequent daytime sleep attacks. Symptoms of narcolepsy include excessive daytime sleepiness (EDS), cataplexy, hallucinati......" | 29-Jul-2022 | $2000 | |
Low Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... w Back Pain (Central Nervous System) pipeline landscape.
Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, or injury, aging, arthritis, illness and cancer involving the ......" | 29-Jul-2022 | $2000 | |
Osteoarthritis Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... ew of the Osteoarthritis Pain (Central Nervous System) pipeline landscape.
Osteoarthritis pain is the most common symptom associated with osteoarthritis which causes disruption of the cartilage. If the condition worsens, it leads to rubb......" | 29-Jul-2022 | $2000 | |
Binge Eating Disorder Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... erview of the Binge Eating Disorder (Central Nervous System) pipeline landscape.
Binge eating disorder is a serious condition characterized by uncontrollable eating and resulting weight gain. The causes of binge-eating disorder are unkno......" | 29-Jul-2022 | $2000 | |
Global and United States Central Nervous System Disorders Therapeutics Market Report & Forecast 2022-2028By QYResearch Group "...... a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Central Nervous System Disorders......" | 09-Jun-2022 | $4350 | |
Anesthetic Effect Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... f the Anesthetic Effect (Central Nervous System) pipeline landscape.
Anesthetic effect causes a loss of consciousness. The factors that can increase risk of complications include smoking, obstructive sleep apnea, obesity, high blood pres......" | 31-May-2022 | $2000 | |
Mild Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... es an overview of the Mild Cognitive Impairment (Central Nervous System) pipeline landscape.
Mild cognitive impairment (MCI) is a condition involving problems with cognitive function (such as thinking, knowing and remembering). MCI is an......" | 31-May-2022 | $2000 | |
Neuromyelitis Optica (Devic's Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 UpdateBy Global Markets Direct "...... In Development, 2022, provides an overview of the Neuromyelitis Optica (Devic's Syndrome) (Central Nervous System) pipeline landscape.
Neuromyelitis optica (NMO), also known as Devic's disease, is an uncommon neurological condition cause......" | 31-May-2022 | $2000 | |
| | |||